TWSTHealthcareMid-Cap

Twist Bioscience Corp Insider Trading Activity

Every SEC Form 4 insider transaction reported for Twist Bioscience Corp (TWST), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are TWST insiders buying or selling?

Twist Bioscience Corp insiders reported 4 open-market buys ($2.5M) and 477 sells ($245.2M) across 481 Form 4 filings — a net selling position of $242.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 13, 2026)

Total Form 4 filings
481
SEC EDGAR
Insider filers
18
Insider buys (4)
$2.5M
Insider sells (477)
$245.2M

Insider sentiment

Net selling

Net insider flow of $242.7M in net selling.

Recent TWST insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 13, 2026Adam LaponisChief Financial OfficerSale2.4K$94.33$226.3K
Jun 26, 2026Emily M. LeproustChief Executive OfficerSale18.9K$95.00$1.8M
Jun 26, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretarySale14.2K$89.75$1.3M
Jun 24, 2026Paula GreenSVP of Human ResourcesSale291$87.32$25.4K
Jun 24, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretarySale346$87.32$30.2K
Jun 24, 2026Emily M. LeproustChief Executive OfficerSale1.7K$87.32$147.4K
Jun 17, 2026Paula GreenSVP of Human ResourcesSale26.1K$81.67$2.1M
Jun 10, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretarySale402$69.84$28.1K
Jun 10, 2026Paula GreenSVP of Human ResourcesSale884$69.84$61.7K
Jun 10, 2026Emily M. LeproustChief Executive OfficerSale2.3K$69.84$158.2K
Jun 10, 2026Robert F. WernerChief Accounting OfficerSale1.4K$69.20$94.0K
Jun 2, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretarySale14.2K$69.75$990.8K
Jun 2, 2026Adam LaponisChief Financial OfficerSale4.0K$70.00$280.0K
Jun 1, 2026Emily M. LeproustChief Executive OfficerSale16.5K$67.91$1.1M
Jun 1, 2026Melissa A. StarovasnikDirectorSale2.5K$68.00$170.0K
May 28, 2026Melissa A. StarovasnikDirectorSale500$61.04$30.5K
May 28, 2026Emily M. LeproustChief Executive OfficerSale49.3K$65.19$3.2M
May 28, 2026Robert F. WernerChief Accounting OfficerSale800$62.48$50.0K
May 26, 2026Paula GreenSVP of Human ResourcesSale1.4K$53.26$74.5K
May 26, 2026Patrick John FinnPresident and COOSale4.2K$53.26$221.5K
May 26, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretarySale1.6K$53.26$87.4K
May 26, 2026Robert F. WernerChief Accounting OfficerSale688$53.26$36.6K
May 26, 2026Emily M. LeproustChief Executive OfficerSale6.9K$53.26$366.8K
May 26, 2026Adam LaponisChief Financial OfficerSale2.0K$53.26$107.5K
May 14, 2026Jan JohannessenDirectorSale12.0K$56.12$673.4K

Showing the 25 most recent of 481 Form 4 filings for Twist Bioscience Corp.

Most active TWST insiders

  • Emily M. Leproust85 filings
  • Patrick John Finn71 filings
  • Dennis Cho59 filings
  • Paula Green59 filings
  • William Banyai44 filings

Ask anything about TWST insider activity

Use Trabud's AI agent to query Twist Bioscience Corp's Form 4 history in plain English — "Show me TWST CEO purchases this year" or compare it against any other ticker.

Open the AI agent

TWST insider trading FAQ

Are Twist Bioscience Corp insiders buying or selling?

Across 481 SEC Form 4 filings, Twist Bioscience Corp (TWST) insiders reported 4 open-market purchases totaling $2.5M and 477 sales totaling $245.2M. That is a net selling position of $242.7M.

How many insiders trade TWST stock?

18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Twist Bioscience Corp. The most recent filing was accepted on Jul 13, 2026.

Where does Trabud get TWST insider trading data?

All TWST insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content